Physician profile
William Patrick
NPI 1205920832
$6,046.56
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,953 · 2020: $93.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,373.91 | 2019 | |
| Lilly USA, LLC | $238.42 | 2019-2020 | |
| Janssen Biotech, INC. | $194.28 | 2019-2020 | |
| Abbvie INC. | $181.29 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $160.77 | 2019 | |
| Prugen, INC. Pharmaceuticals | $124.00 | 2019 | |
| Almirall LLC | $122.15 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $118.31 | 2019 | |
| Amgen INC. | $96.61 | 2019-2020 | |
| Leo Pharma INC. | $67.34 | 2019-2020 | |
| Sandoz INC. | $62.26 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $60.22 | 2019 | |
| Ucb, INC. | $58.05 | 2019 | |
| Galderma Laboratories, L.P. | $53.76 | 2019 | |
| Celgene Corporation | $47.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $40.37 | 2019 | |
| Genzyme Corporation | $16.10 | 2019 | |
| Kyowa Kirin, INC. | $16.04 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $14.77 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.